In this context, we are pleased to share the launch of the Ion Torrent™ Oncomine™ Clinical Research Grant Program 2026, an important funding opportunity in the fields of oncology and precision medicine.
Through this program, Thermo Fisher Scientific invites researchers to submit innovative proposals that leverage next-generation sequencing (NGS) technologies for cancer molecular profiling, with the aim of addressing unmet research needs and further advancing precision medicine.
Apply now!
Application Deadline: June 15, 2026
Applications should include a clear and well-documented description of the proposed research project, along with a detailed budget demonstrating the optimal use of the requested funding. Results will be announced within 6–8 weeks of the deadline.
- Maximum budget per project: up to $200,000
- Maximum project duration: up to 12 months
It is also worth noting that, to date, Thermo Fisher Scientific has awarded nearly $5 million to laboratories worldwide for their exceptional work in cancer genomic profiling.
By participating in the Oncomine Clinical Research Grant Program, you will join a community of researchers dedicated to advancing precision medicine and making a significant impact in the field of cancer research.
With ANTISEL’s guidance
The ANTISEL team remains at your disposal for further information, as well as for support throughout the application process.